ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/09/17 | 2,511 | 2,554 | 2,490 | 2,499 | -42 | -1.7% | 881,800 |
2025/09/16 | 2,570 | 2,570 | 2,492 | 2,541 | -44 | -1.7% | 1,182,800 |
2025/09/12 | 2,623 | 2,623 | 2,582 | 2,585 | -15 | -0.6% | 660,700 |
2025/09/11 | 2,647 | 2,662 | 2,589 | 2,600 | -6 | -0.2% | 784,000 |
2025/09/10 | 2,632 | 2,642 | 2,575 | 2,606 | -47 | -1.8% | 884,600 |
2025/09/09 | 2,646 | 2,710 | 2,632 | 2,653 | +21 | +0.8% | 822,900 |
2025/09/08 | 2,705 | 2,709 | 2,631 | 2,632 | -39 | -1.5% | 1,260,300 |
2025/09/05 | 2,670 | 2,685 | 2,651 | 2,671 | -3 | -0.1% | 607,500 |
2025/09/04 | 2,600 | 2,679 | 2,594 | 2,674 | +73 | +2.8% | 1,031,400 |
2025/09/03 | 2,620 | 2,629 | 2,581 | 2,601 | -69 | -2.6% | 1,393,200 |
2025/09/02 | 2,696 | 2,714 | 2,654 | 2,670 | -21 | -0.8% | 1,018,200 |
2025/09/01 | 2,641 | 2,703 | 2,622 | 2,691 | ±0 | ±0% | 971,100 |
2025/08/29 | 2,670 | 2,705 | 2,620 | 2,691 | +34 | +1.3% | 1,388,500 |
2025/08/28 | 2,651 | 2,673 | 2,626 | 2,657 | +12 | +0.5% | 712,200 |
2025/08/27 | 2,665 | 2,685 | 2,602 | 2,645 | -12 | -0.5% | 965,300 |
2025/08/26 | 2,716 | 2,720 | 2,649 | 2,657 | -83 | -3% | 1,223,500 |
2025/08/25 | 2,750 | 2,783 | 2,730 | 2,740 | +70 | +2.6% | 1,300,300 |
2025/08/22 | 2,675 | 2,678 | 2,611 | 2,670 | -8 | -0.3% | 1,463,700 |
2025/08/21 | 2,670 | 2,720 | 2,661 | 2,678 | +5 | +0.2% | 1,342,600 |
2025/08/20 | 2,805 | 2,806 | 2,654 | 2,673 | -167 | -5.9% | 2,516,800 |
2025/08/19 | 2,820 | 2,875 | 2,807 | 2,840 | +35 | +1.2% | 1,253,400 |
2025/08/18 | 2,998 | 3,005 | 2,796 | 2,805 | -178 | -6% | 3,027,300 |
2025/08/15 | 3,105 | 3,160 | 2,905 | 2,983 | +98 | +3.4% | 3,001,200 |
2025/08/14 | 2,849 | 2,911 | 2,832 | 2,885 | +45 | +1.6% | 1,119,100 |
2025/08/13 | 2,926 | 2,934 | 2,840 | 2,840 | -60 | -2.1% | 1,454,400 |
2025/08/12 | 2,950 | 2,951 | 2,861 | 2,900 | -68 | -2.3% | 1,536,000 |
2025/08/08 | 3,020 | 3,025 | 2,955 | 2,968 | -37 | -1.2% | 1,268,900 |
2025/08/07 | 2,913 | 3,010 | 2,880 | 3,005 | +92 | +3.2% | 1,308,400 |
2025/08/06 | 2,922 | 2,967 | 2,890 | 2,913 | -8 | -0.3% | 1,146,700 |
2025/08/05 | 2,890 | 2,948 | 2,848 | 2,921 | +81 | +2.9% | 1,279,500 |
2025/08/04 | 2,750 | 2,864 | 2,747 | 2,840 | +48 | +1.7% | 1,226,600 |
2025/08/01 | 2,785 | 2,822 | 2,770 | 2,792 | -10 | -0.4% | 983,700 |
2025/07/31 | 2,815 | 2,841 | 2,783 | 2,802 | -13 | -0.5% | 1,318,300 |
2025/07/30 | 2,825 | 2,836 | 2,787 | 2,815 | +15 | +0.5% | 906,900 |
2025/07/29 | 2,818 | 2,880 | 2,755 | 2,800 | -6 | -0.2% | 1,724,300 |
2025/07/28 | 2,804 | 2,858 | 2,786 | 2,806 | +52 | +1.9% | 2,082,100 |
2025/07/25 | 2,761 | 2,775 | 2,685 | 2,754 | -112 | -3.9% | 4,703,400 |
2025/07/24 | 2,990 | 3,135 | 2,817 | 2,866 | -209 | -6.8% | 5,644,600 |
2025/07/23 | 3,060 | 3,125 | 3,040 | 3,075 | +55 | +1.8% | 644,900 |
2025/07/22 | 3,030 | 3,055 | 3,005 | 3,020 | -25 | -0.8% | 467,600 |
2025/07/18 | 3,100 | 3,120 | 3,015 | 3,045 | -50 | -1.6% | 852,000 |
2025/07/17 | 3,070 | 3,115 | 3,060 | 3,095 | +45 | +1.5% | 775,700 |
2025/07/16 | 3,010 | 3,075 | 2,981 | 3,050 | +10 | +0.3% | 992,400 |
2025/07/15 | 3,090 | 3,125 | 3,030 | 3,040 | -35 | -1.1% | 834,800 |
2025/07/14 | 3,080 | 3,095 | 3,040 | 3,075 | -45 | -1.4% | 666,400 |
2025/07/11 | 3,120 | 3,190 | 3,095 | 3,120 | +15 | +0.5% | 1,314,200 |
2025/07/10 | 3,105 | 3,150 | 3,030 | 3,105 | ±0 | ±0% | 1,277,200 |
2025/07/09 | 3,090 | 3,120 | 3,050 | 3,105 | +45 | +1.5% | 1,031,400 |
2025/07/08 | 3,020 | 3,100 | 3,015 | 3,060 | -25 | -0.8% | 1,085,700 |
2025/07/07 | 3,130 | 3,165 | 3,045 | 3,085 | -30 | -1% | 1,619,000 |
1~
50
件表示中 / 3785件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 249,900円 | +21.7% | +999.9% | 0.00% | 11.51倍 | 3.94倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
科研薬 | 385,000円 | -6.4% | -71.8% | 4.94% | 42.88倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 292,000円 | +7.9% | -3.3% | 2.74% | 8.12倍 | 0.84倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
持田薬 | 320,500円 | +5.1% | -7.0% | 2.50% | 21.04倍 | 0.87倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 209,900円 | +3.1% | -6.5% | 2.29% | 9.74倍 | 1.03倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム